T.J. Eberlein

2.0k total citations
60 papers, 1.3k citations indexed

About

T.J. Eberlein is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T.J. Eberlein has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 22 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T.J. Eberlein's work include Breast Cancer Treatment Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Gastric Cancer Management and Outcomes (10 papers). T.J. Eberlein is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Gastric Cancer Management and Outcomes (10 papers). T.J. Eberlein collaborates with scholars based in United States, Germany and United Kingdom. T.J. Eberlein's co-authors include Ichiro Yoshino, George E. Peoples, David C. Linehan, Robert W. Smith, Peter S. Goedegebuure, Deric D. Schoof, S J Schnitt, Barbara Silver, Daniel Hayes and Anthony Abner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

T.J. Eberlein

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.J. Eberlein United States 14 581 461 380 317 298 60 1.3k
Schlomo Schneebaum Israel 17 574 1.0× 164 0.4× 225 0.6× 186 0.6× 232 0.8× 54 1.1k
D. Vena United States 12 585 1.0× 251 0.5× 126 0.3× 376 1.2× 166 0.6× 13 1.4k
Sebastian Leibl Austria 17 475 0.8× 195 0.4× 225 0.6× 328 1.0× 276 0.9× 29 1.3k
Michael A. Morse United States 13 1.8k 3.0× 465 1.0× 365 1.0× 650 2.1× 321 1.1× 24 2.1k
Jun Zhu China 20 450 0.8× 236 0.5× 327 0.9× 294 0.9× 101 0.3× 104 1.4k
Martin Poleski United States 12 548 0.9× 170 0.4× 193 0.5× 176 0.6× 289 1.0× 18 1.2k
Cécile Charpy France 13 661 1.1× 357 0.8× 194 0.5× 139 0.4× 194 0.7× 29 1.2k
Willeke Ros Netherlands 14 1.6k 2.8× 593 1.3× 194 0.5× 223 0.7× 666 2.2× 22 2.2k
Todd S. Crocenzi United States 23 1.6k 2.8× 623 1.4× 254 0.7× 354 1.1× 461 1.5× 59 2.3k
Wataru Yamagami Japan 24 641 1.1× 402 0.9× 349 0.9× 175 0.6× 212 0.7× 124 2.0k

Countries citing papers authored by T.J. Eberlein

Since Specialization
Citations

This map shows the geographic impact of T.J. Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.J. Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.J. Eberlein more than expected).

Fields of papers citing papers by T.J. Eberlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.J. Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.J. Eberlein. The network helps show where T.J. Eberlein may publish in the future.

Co-authorship network of co-authors of T.J. Eberlein

This figure shows the co-authorship network connecting the top 25 collaborators of T.J. Eberlein. A scholar is included among the top collaborators of T.J. Eberlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.J. Eberlein. T.J. Eberlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberlein, T.J.. (2012). gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma. Yearbook of Surgery. 2012. 350–352. 8 indexed citations
2.
Eberlein, T.J.. (2011). Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy. Yearbook of Surgery. 2011. 306–307. 2 indexed citations
3.
Eberlein, T.J.. (2011). Preoperative Biliary Drainage for Cancer of the Head of the Pancreas. Yearbook of Surgery. 2011. 314–316. 19 indexed citations
4.
5.
6.
Eberlein, T.J.. (2010). Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma. Yearbook of Surgery. 2010. 349–349. 1 indexed citations
7.
Eberlein, T.J.. (2010). Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients. Yearbook of Surgery. 2010. 341–343. 1 indexed citations
8.
Eberlein, T.J.. (2008). Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 and 4: Prognostic Factors and Longterm Outcomes. Yearbook of Surgery. 2008. 344–346. 2 indexed citations
9.
Eberlein, T.J.. (2008). Longterm Favorable Results of Limited Hepatic Resections for Patients with Hepatocellular Carcinoma: 20 Years of Experience. Yearbook of Surgery. 2008. 350–352. 4 indexed citations
10.
Eberlein, T.J.. (2007). Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. Yearbook of Surgery. 2007. 304–305. 3 indexed citations
11.
12.
Eberlein, T.J.. (2007). Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. Yearbook of Surgery. 2007. 319–320. 3 indexed citations
13.
Eberlein, T.J.. (2006). A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer. Yearbook of Surgery. 2006. 317–319. 1 indexed citations
14.
Peiper, Matthias, P S Goedegebuure, Jakob R. Izbicki, & T.J. Eberlein. (1999). Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu.. PubMed. 19(4A). 2471–5. 11 indexed citations
15.
Peoples, George E., Peter S. Goedegebuure, Robert W. Smith, et al.. (1995). Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.. Proceedings of the National Academy of Sciences. 92(2). 432–436. 372 indexed citations
16.
Abner, Anthony, Abram Recht, T.J. Eberlein, et al.. (1993). Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer.. Journal of Clinical Oncology. 11(1). 44–48. 164 indexed citations
17.
Schoof, Deric D., et al.. (1992). The biological effects of immunosuppression on cellular immunotherapy. Surgical Oncology. 1(1). 27–35. 8 indexed citations
18.
Kress, Hans G. & T.J. Eberlein. (1992). Wirkung von Anästhesie und Operation auf wesentliche Immunfunktionen. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 27(7). 393–402. 10 indexed citations
19.
Schoof, Deric D., et al.. (1988). Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells.. PubMed. 48(17). 5007–10. 73 indexed citations
20.
Eberlein, T.J., et al.. (1988). Efficacy of specimen radiography of clinically occult noncalcified breast lesions. American Journal of Roentgenology. 151(1). 43–47. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Schlomo Schneebaum Breakdown of academic impact, for papers by D. Vena Breakdown of academic impact, for papers by Sebastian Leibl Breakdown of academic impact, for papers by Michael A. Morse Breakdown of academic impact, for papers by Jun Zhu Breakdown of academic impact, for papers by Martin Poleski Breakdown of academic impact, for papers by Cécile Charpy Breakdown of academic impact, for papers by Willeke Ros Breakdown of academic impact, for papers by Todd S. Crocenzi Breakdown of academic impact, for papers by Wataru Yamagami
Rankless by CCL
2026